Jadelle

Levonorgestrel, the active ingredient in Jadelle, is a progestin presented as a 150 mg total (2 × 75 mg rods) subdermal implant for subcutaneous use. It provides long‑acting reversible contraception by preventing ovulation and implantation in women of reproductive age.

GNH USA supplies Jadelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and offers reliable global logistics for this contraceptive device, providing consistent batch release, regulatory support, and dedicated technical assistance.

Levonorgestrel is a progestin used in hormonal contraception to provide long‑acting reversible birth control. - Contraception: Provides up to five years of pregnancy prevention for women seeking a reliable, reversible method. - Family planning: Enables effective birth control without daily dosing, supporting long‑term reproductive planning. - Prevention of unintended pregnancy: Reduces the risk of unintended pregnancy in sexually active women.

Levonorgestrel implants may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Insertion site pain: Discomfort or soreness at the implant insertion site. - Irregular bleeding: Spotting, prolonged bleeding, or amenorrhea. - Headache: Mild to moderate headache episodes. - Acne: New or worsening acne lesions.

Serious or Rare Side Effects: - Ectopic pregnancy: Pregnancy occurring outside the uterus despite implant use. - Pelvic inflammatory disease: Infection of the reproductive organs. - Implant migration: Movement of the rod from the original insertion site. - Allergic reaction: Rash, swelling, or anaphylaxis in response to the device.

Before using Jadelle, certain precautions should be observed to ensure safety and effectiveness. - Pregnancy testing: Verify non‑pregnant status prior to insertion. - Breastfeeding: Discuss potential risks with a healthcare professional before placement. - Hormone‑sensitive conditions: Avoid use in women with a history of breast cancer or estrogen‑dependent tumors. - Medication interactions: Review concomitant drugs that may reduce contraceptive efficacy. - Follow‑up: Schedule regular visits to assess implant position and bleeding patterns. - Store at ambient temperature: Keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel implants can interact with other medicines, affecting their effectiveness or safety.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine): May significantly lower levonorgestrel levels, reducing contraceptive protection. - Antiretroviral drugs (e.g., efavirenz): Can decrease hormone concentrations and increase risk of unintended pregnancy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): May increase levonorgestrel exposure, potentially enhancing side effects. - Certain antibiotics (e.g., ampicillin): Generally minimal effect but should be monitored for any changes in bleeding. - Herbal supplements (e.g., St. John’s wort): May induce metabolism and lower implant efficacy.